Skip to Main Content
Legislation Search

S. 977: End Taxpayer Funding of Gender Experimentation Act of 2025

This bill, titled the "End Taxpayer Funding of Gender Experimentation Act of 2025," aims to prohibit the use of taxpayer dollars for gender transition procedures in the United States. Here’s an overview of its main provisions:

Prohibition on Funding for Gender Transition Procedures

The bill outlines specific restrictions on federal funding related to gender transition procedures. Key points include:

  • No federal funds can be used for any gender transition procedures, which includes surgical and hormonal interventions.
  • Restrictions on health benefits plans: Plans that provide coverage for gender transition procedures cannot use federal funds to cover these costs.
  • Health care services provided in federal facilities or by federal employees may not include gender transition procedures.
  • Individuals are still allowed to purchase separate coverage for gender transition procedures, but this must be done with non-federal funds.
  • The bill clarifies that complications arising from gender transition procedures can still be treated, indicating that related health issues will not be affected by this funding prohibition.

Application to the Affordable Care Act

The bill provides amendments to the Affordable Care Act (ACA) to align with its prohibitions:

  • Premium Credits and Cost-Sharing Reductions: The bill disallows any refundable credit or cost-sharing reductions for health plans that provide coverage for gender transition procedures.
  • Exclusions for Small Employer Health Insurance: Small employer tax credits for health insurance expenses will not be available for plans that cover gender transition procedures.
  • Multi-state plans must comply with federal policies prohibiting federal funding for gender transition procedures.

Definitions

The bill includes specific definitions for terms related to gender transition. For instance:

  • Gender transition is defined as the process of changing one's gender identity, which may include social, legal, or physical changes.
  • Gender transition procedures encompass a wide range of medical interventions aimed at transitioning from one gender to another.

Exemptions

Certain procedures are exempt from the funding prohibitions, such as:

  • Treatments related to medically verifiable disorders of sex development.
  • Procedures for individuals with physical conditions that require immediate intervention.
  • Prescriptions for puberty suppression for minors experiencing precocious puberty, among other exceptions.

Effective Date

The provisions in the bill would go into effect one year after its enactment, specifically for tax years and plan years starting after that date.

Relevant Companies

None found

This is an AI-generated summary of the bill text. There may be mistakes.

Show More

Sponsors

13 bill sponsors

Actions

2 actions

Date Action
Mar. 12, 2025 Introduced in Senate
Mar. 12, 2025 Read twice and referred to the Committee on Finance.

Corporate Lobbying

0 companies lobbying

None found.

* Note that there can be significant delays in lobbying disclosures, and our data may be incomplete.

Potentially Relevant Congressional Stock Trades

No relevant congressional stock trades found.